Latest News & Features
Americas
Pharmaceutical companies Teva and Mylan have each been granted permission to market a generic version of Novartis’s blood pressure treatment Diovan (valsartan) in the US. 8 January 2015
Big Pharma
Police in the UK have charged a man after accusing him of selling counterfeit drugs including erectile dysfunction and abortion medicines online. 7 January 2015
Americas
The US Food and Drug Administration has recommended that an application by pharmaceutical company Novartis to market a biosimilar version of Amgen’s cancer drug Neupogen (filgrastim) be approved. 5 January 2015
Americas
US pharmaceutical company Strategic Science and Technologies has signed an option agreement with “one of the world’s largest over-the-counter healthcare companies” to commercialise one of its ibuprofen products. 22 December 2014
Americas
A US biotechnology company that was on the winning side of an EU court ruling surrounding the patentability of certain organisms has said it “clears the way” for patents in Europe. 19 December 2014
Americas
Law firm Fitzpatrick, Cella, Harper, & Scinto will begin the New Year with three new faces in its partnership. 19 December 2014
article
The battle between innovative pharma companies and generic drug rivals is a constant source of interest. 19 December 2014
Big Pharma
A decision by the CJEU on a Latvian case should make it easier in the future to challenge an MA granted for a generic version of a reference product, as Trevor Cook of WilmerHale explains. 19 December 2014
Europe
Bringing a ‘repurposed’ drug to market requires a clear patent strategy, but clarity is unfortunately lacking in this field, say Simon Kremer and Rachel Jones of law firm Mewburn Ellis. 19 December 2014
Americas
Maximising the strength of patent protection should be an important objective of any R&D pharma company. Christine Goddard and Janis Fraser of law firm Fish & Richardson offer their six top tips for success. 19 December 2014